VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Friday, January 2, 2026

Stock Comparison

AstraZeneca PLC vs Altria Group, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

AstraZeneca PLC

AZN · London Stock Exchange

Market cap (USD)
Gross margin (TTM)
Operating margin (TTM)
Net margin (TTM)
SectorHealthcare
Industry
CountryGB
Data as of2026-01-02
Moat score
71/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.

View AZN analysis

Altria Group, Inc.

MO · New York Stock Exchange

Market cap (USD)$96.7B
Gross margin (TTM)72%
Operating margin (TTM)55.2%
Net margin (TTM)44%
SectorConsumer
IndustryTobacco
CountryUS
Data as of2025-12-30
Moat score
88/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Altria Group, Inc.'s moat claims, evidence, and risks.

View MO analysis

Comparison highlights

  • Moat score gap: Altria Group, Inc. leads (88 / 100 vs 71 / 100 for AstraZeneca PLC).
  • Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Altria Group, Inc. has 3 segments (88.3% in Smokeable Products).
  • Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Altria Group, Inc. has 5 across 3.

Primary market context

AstraZeneca PLC

Oncology

Market

Innovator oncology therapeutics (branded prescription medicines)

Geography

Global

Customer

Hospitals, oncology clinics, payers

Role

Innovator biopharmaceutical company

Revenue share

41%

Altria Group, Inc.

Smokeable Products

Market

U.S. cigarettes and machine-made cigars

Geography

United States

Customer

Wholesalers/distributors and large retail organizations (serving adult tobacco consumers 21+)

Role

Manufacturer and brand owner

Revenue share

88.3%

Side-by-side metrics

AstraZeneca PLC
Altria Group, Inc.
Ticker / Exchange
AZN - London Stock Exchange
MO - New York Stock Exchange
Market cap (USD)
n/a
$96.7B
Gross margin (TTM)
n/a
72%
Operating margin (TTM)
n/a
55.2%
Net margin (TTM)
n/a
44%
Sector
Healthcare
Consumer
Industry
n/a
Tobacco
HQ country
GB
US
Primary segment
Oncology
Smokeable Products
Market structure
Oligopoly
Oligopoly
Market share
n/a
45.9% (reported)
HHI estimate
n/a
n/a
Pricing power
Strong
Strong
Moat score
71 / 100
88 / 100
Moat domains
Legal, Supply, Demand
Demand, Financial, Legal
Last update
2026-01-02
2025-12-30

Moat coverage

Shared moat types

Regulated Standards PipeBrand Trust

AstraZeneca PLC strengths

IP Choke PointCapex Knowhow Scale

Altria Group, Inc. strengths

Habit DefaultBenchmark Pricing PowerCompliance Advantage

Segment mix

AstraZeneca PLC segments

Full profile >

Oncology

Oligopoly

41%

Cardiovascular, Renal and Metabolism (CVRM)

Competitive

23%

Respiratory & Immunology (R&I)

Oligopoly

15%

Vaccines & Immune Therapies (V&I)

Oligopoly

3%

Rare Disease

Oligopoly

16%

Other Medicines

Competitive

2%

Altria Group, Inc. segments

Full profile >

Smokeable Products

Oligopoly

88.3%

Oral Tobacco Products

Oligopoly

11.6%

E-Vapor and New Products (NJOY, Horizon, R&D)

Competitive

0.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.